nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PTGS2—lung cancer	0.382	1	CbGaD
Drospirenone—BCHE—Irinotecan—lung cancer	0.0991	0.327	CbGbCtD
Drospirenone—BCHE—Cisplatin—lung cancer	0.0808	0.267	CbGbCtD
Drospirenone—PTGS2—Cisplatin—lung cancer	0.0621	0.205	CbGbCtD
Drospirenone—PTGS2—Etoposide—lung cancer	0.0611	0.201	CbGbCtD
Drospirenone—BCHE—diaphragm—lung cancer	0.0132	0.265	CbGeAlD
Drospirenone—Thromboembolic event—Vinorelbine—lung cancer	0.00564	0.0364	CcSEcCtD
Drospirenone—Thromboembolic event—Irinotecan—lung cancer	0.00465	0.03	CcSEcCtD
Drospirenone—Embolism—Pemetrexed—lung cancer	0.00461	0.0297	CcSEcCtD
Drospirenone—Thrombosis—Pemetrexed—lung cancer	0.00418	0.0269	CcSEcCtD
Drospirenone—Cerebral infarction—Irinotecan—lung cancer	0.00384	0.0248	CcSEcCtD
Drospirenone—Infarction—Paclitaxel—lung cancer	0.00368	0.0237	CcSEcCtD
Drospirenone—PGR—mammary gland—lung cancer	0.0035	0.0702	CbGeAlD
Drospirenone—Thromboembolic event—Docetaxel—lung cancer	0.00322	0.0207	CcSEcCtD
Drospirenone—Embolism—Vinorelbine—lung cancer	0.00237	0.0153	CcSEcCtD
Drospirenone—PGR—respiratory system—lung cancer	0.00233	0.0468	CbGeAlD
Drospirenone—Thromboembolic event—Methotrexate—lung cancer	0.00232	0.0149	CcSEcCtD
Drospirenone—Cerebrovascular accident—Pemetrexed—lung cancer	0.00219	0.0141	CcSEcCtD
Drospirenone—Thrombosis—Vinorelbine—lung cancer	0.00215	0.0138	CcSEcCtD
Drospirenone—NR3C2—bronchus—lung cancer	0.00207	0.0414	CbGeAlD
Drospirenone—Mood swings—Pemetrexed—lung cancer	0.00203	0.0131	CcSEcCtD
Drospirenone—Embolism—Irinotecan—lung cancer	0.00195	0.0126	CcSEcCtD
Drospirenone—PGR—epithelium—lung cancer	0.00195	0.0391	CbGeAlD
Drospirenone—NR3C2—trachea—lung cancer	0.00185	0.0372	CbGeAlD
Drospirenone—Venous thromboembolism—Doxorubicin—lung cancer	0.00184	0.0119	CcSEcCtD
Drospirenone—Thrombosis—Irinotecan—lung cancer	0.00177	0.0114	CcSEcCtD
Drospirenone—NR3C2—cardiac atrium—lung cancer	0.00174	0.0349	CbGeAlD
Drospirenone—Acute coronary syndrome—Pemetrexed—lung cancer	0.00163	0.0105	CcSEcCtD
Drospirenone—Myocardial infarction—Pemetrexed—lung cancer	0.00162	0.0105	CcSEcCtD
Drospirenone—Embolism—Paclitaxel—lung cancer	0.00159	0.0103	CcSEcCtD
Drospirenone—AR—epithelium—lung cancer	0.00155	0.0311	CbGeAlD
Drospirenone—AR—bronchus—lung cancer	0.00153	0.0307	CbGeAlD
Drospirenone—BCHE—respiratory system—lung cancer	0.00151	0.0303	CbGeAlD
Drospirenone—Haemoglobin—Gefitinib—lung cancer	0.00148	0.00956	CcSEcCtD
Drospirenone—Haemorrhage—Gefitinib—lung cancer	0.00148	0.00951	CcSEcCtD
Drospirenone—Thrombosis—Paclitaxel—lung cancer	0.00144	0.0093	CcSEcCtD
Drospirenone—Erythema multiforme—Pemetrexed—lung cancer	0.0014	0.00905	CcSEcCtD
Drospirenone—Erythema multiforme—Gefitinib—lung cancer	0.0014	0.00899	CcSEcCtD
Drospirenone—Cerebrovascular accident—Vinblastine—lung cancer	0.00135	0.00873	CcSEcCtD
Drospirenone—Loss of libido—Methotrexate—lung cancer	0.00135	0.00871	CcSEcCtD
Drospirenone—Embolism—Docetaxel—lung cancer	0.00135	0.0087	CcSEcCtD
Drospirenone—Angiopathy—Gefitinib—lung cancer	0.00134	0.00863	CcSEcCtD
Drospirenone—NR3C2—lung—lung cancer	0.00133	0.0267	CbGeAlD
Drospirenone—Cerebrovascular accident—Erlotinib—lung cancer	0.0013	0.00839	CcSEcCtD
Drospirenone—AR—cardiac atrium—lung cancer	0.00129	0.0259	CbGeAlD
Drospirenone—BCHE—bronchus—lung cancer	0.00124	0.0249	CbGeAlD
Drospirenone—PGR—lung—lung cancer	0.00124	0.0248	CbGeAlD
Drospirenone—Haemoglobin—Teniposide—lung cancer	0.00121	0.00779	CcSEcCtD
Drospirenone—Haemorrhage—Teniposide—lung cancer	0.0012	0.00775	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Crizotinib—lung cancer	0.0012	0.00771	CcSEcCtD
Drospirenone—Breast pain—Paclitaxel—lung cancer	0.00117	0.00755	CcSEcCtD
Drospirenone—PTGS2—respiratory system—lung cancer	0.00117	0.0233	CbGeAlD
Drospirenone—Nervous system disorder—Crizotinib—lung cancer	0.00113	0.0073	CcSEcCtD
Drospirenone—Cerebrovascular accident—Vinorelbine—lung cancer	0.00113	0.00725	CcSEcCtD
Drospirenone—Skin disorder—Crizotinib—lung cancer	0.00112	0.00723	CcSEcCtD
Drospirenone—BCHE—trachea—lung cancer	0.00112	0.0224	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Pemetrexed—lung cancer	0.00109	0.00705	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Gefitinib—lung cancer	0.00109	0.007	CcSEcCtD
Drospirenone—Embolism venous—Doxorubicin—lung cancer	0.00107	0.0069	CcSEcCtD
Drospirenone—Hydrocortisone—ANXA1—lung cancer	0.00107	0.234	CrCbGaD
Drospirenone—BCHE—cardiac atrium—lung cancer	0.00105	0.021	CbGeAlD
Drospirenone—Nervous system disorder—Pemetrexed—lung cancer	0.00103	0.00667	CcSEcCtD
Drospirenone—Nervous system disorder—Gefitinib—lung cancer	0.00103	0.00663	CcSEcCtD
Drospirenone—Skin disorder—Pemetrexed—lung cancer	0.00103	0.00661	CcSEcCtD
Drospirenone—Depression—Vinblastine—lung cancer	0.00102	0.00657	CcSEcCtD
Drospirenone—Skin disorder—Gefitinib—lung cancer	0.00102	0.00656	CcSEcCtD
Drospirenone—Acute coronary syndrome—Vinblastine—lung cancer	0.00101	0.0065	CcSEcCtD
Drospirenone—Myocardial infarction—Vinblastine—lung cancer	0.001	0.00646	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Crizotinib—lung cancer	0.000997	0.00643	CcSEcCtD
Drospirenone—AR—lung—lung cancer	0.000987	0.0198	CbGeAlD
Drospirenone—Depression—Erlotinib—lung cancer	0.00098	0.00632	CcSEcCtD
Drospirenone—PTGS2—epithelium—lung cancer	0.000974	0.0195	CbGeAlD
Drospirenone—Embolism—Methotrexate—lung cancer	0.000972	0.00627	CcSEcCtD
Drospirenone—Acute coronary syndrome—Erlotinib—lung cancer	0.000969	0.00624	CcSEcCtD
Drospirenone—Myocardial infarction—Erlotinib—lung cancer	0.000963	0.00621	CcSEcCtD
Drospirenone—PTGS2—bronchus—lung cancer	0.000959	0.0192	CbGeAlD
Drospirenone—Cerebrovascular accident—Irinotecan—lung cancer	0.000928	0.00598	CcSEcCtD
Drospirenone—Testosterone Propionate—UGT1A1—lung cancer	0.000925	0.203	CrCbGaD
Drospirenone—Haemoglobin—Vinblastine—lung cancer	0.000923	0.00595	CcSEcCtD
Drospirenone—Haemorrhage—Vinblastine—lung cancer	0.000918	0.00592	CcSEcCtD
Drospirenone—NR3C2—lymph node—lung cancer	0.000912	0.0183	CbGeAlD
Drospirenone—Gastrointestinal disorder—Pemetrexed—lung cancer	0.000911	0.00587	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Gefitinib—lung cancer	0.000905	0.00583	CcSEcCtD
Drospirenone—Cerebrovascular accident—Gemcitabine—lung cancer	0.000904	0.00583	CcSEcCtD
Drospirenone—Haemoglobin—Topotecan—lung cancer	0.000896	0.00578	CcSEcCtD
Drospirenone—Haemorrhage—Topotecan—lung cancer	0.000892	0.00575	CcSEcCtD
Drospirenone—Haemoglobin—Erlotinib—lung cancer	0.000887	0.00572	CcSEcCtD
Drospirenone—BCHE—bone marrow—lung cancer	0.000886	0.0178	CbGeAlD
Drospirenone—Haemorrhage—Erlotinib—lung cancer	0.000882	0.00569	CcSEcCtD
Drospirenone—PTGS2—trachea—lung cancer	0.000861	0.0173	CbGeAlD
Drospirenone—PGR—lymph node—lung cancer	0.000847	0.017	CbGeAlD
Drospirenone—Cerebrovascular accident—Cisplatin—lung cancer	0.000843	0.00543	CcSEcCtD
Drospirenone—Embolism—Doxorubicin—lung cancer	0.000842	0.00543	CcSEcCtD
Drospirenone—Acute coronary syndrome—Vinorelbine—lung cancer	0.000838	0.0054	CcSEcCtD
Drospirenone—Erythema multiforme—Erlotinib—lung cancer	0.000834	0.00538	CcSEcCtD
Drospirenone—Myocardial infarction—Vinorelbine—lung cancer	0.000833	0.00537	CcSEcCtD
Drospirenone—Angiopathy—Topotecan—lung cancer	0.000809	0.00521	CcSEcCtD
Drospirenone—BCHE—lung—lung cancer	0.000803	0.0161	CbGeAlD
Drospirenone—Mental disorder—Erlotinib—lung cancer	0.000773	0.00498	CcSEcCtD
Drospirenone—Thrombosis—Doxorubicin—lung cancer	0.000764	0.00492	CcSEcCtD
Drospirenone—Cerebrovascular accident—Paclitaxel—lung cancer	0.000757	0.00488	CcSEcCtD
Drospirenone—Breast disorder—Cisplatin—lung cancer	0.000746	0.00481	CcSEcCtD
Drospirenone—Mood swings—Paclitaxel—lung cancer	0.000703	0.00453	CcSEcCtD
Drospirenone—Angiopathy—Vinorelbine—lung cancer	0.000692	0.00446	CcSEcCtD
Drospirenone—Acute coronary syndrome—Irinotecan—lung cancer	0.000691	0.00445	CcSEcCtD
Drospirenone—Myocardial infarction—Irinotecan—lung cancer	0.000687	0.00443	CcSEcCtD
Drospirenone—Nausea—Crizotinib—lung cancer	0.000686	0.00442	CcSEcCtD
Drospirenone—PTGS2—bone marrow—lung cancer	0.000683	0.0137	CbGeAlD
Drospirenone—AR—lymph node—lung cancer	0.000675	0.0135	CbGeAlD
Drospirenone—Acute coronary syndrome—Gemcitabine—lung cancer	0.000673	0.00434	CcSEcCtD
Drospirenone—Breast disorder—Paclitaxel—lung cancer	0.00067	0.00432	CcSEcCtD
Drospirenone—Myocardial infarction—Gemcitabine—lung cancer	0.000669	0.00431	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.000656	0.00423	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.000649	0.00419	CcSEcCtD
Drospirenone—Haemoglobin—Irinotecan—lung cancer	0.000632	0.00408	CcSEcCtD
Drospirenone—Haemorrhage—Irinotecan—lung cancer	0.000629	0.00405	CcSEcCtD
Drospirenone—Acute coronary syndrome—Cisplatin—lung cancer	0.000627	0.00404	CcSEcCtD
Drospirenone—Nausea—Pemetrexed—lung cancer	0.000627	0.00404	CcSEcCtD
Drospirenone—Myocardial infarction—Cisplatin—lung cancer	0.000624	0.00402	CcSEcCtD
Drospirenone—Nausea—Gefitinib—lung cancer	0.000623	0.00401	CcSEcCtD
Drospirenone—Nervous system disorder—Topotecan—lung cancer	0.000621	0.004	CcSEcCtD
Drospirenone—Breast pain—Doxorubicin—lung cancer	0.00062	0.00399	CcSEcCtD
Drospirenone—Migraine—Docetaxel—lung cancer	0.000619	0.00399	CcSEcCtD
Drospirenone—PTGS2—lung—lung cancer	0.000619	0.0124	CbGeAlD
Drospirenone—Haemoglobin—Gemcitabine—lung cancer	0.000616	0.00397	CcSEcCtD
Drospirenone—Skin disorder—Topotecan—lung cancer	0.000615	0.00397	CcSEcCtD
Drospirenone—Nervous system disorder—Erlotinib—lung cancer	0.000615	0.00396	CcSEcCtD
Drospirenone—Haemorrhage—Gemcitabine—lung cancer	0.000613	0.00395	CcSEcCtD
Drospirenone—Skin disorder—Erlotinib—lung cancer	0.000609	0.00392	CcSEcCtD
Drospirenone—Erythema multiforme—Gemcitabine—lung cancer	0.00058	0.00373	CcSEcCtD
Drospirenone—Acute coronary syndrome—Etoposide—lung cancer	0.000575	0.0037	CcSEcCtD
Drospirenone—Myocardial infarction—Etoposide—lung cancer	0.000571	0.00368	CcSEcCtD
Drospirenone—Angiopathy—Irinotecan—lung cancer	0.000571	0.00368	CcSEcCtD
Drospirenone—Depression—Paclitaxel—lung cancer	0.00057	0.00367	CcSEcCtD
Drospirenone—Breast disorder—Docetaxel—lung cancer	0.000568	0.00366	CcSEcCtD
Drospirenone—Acute coronary syndrome—Paclitaxel—lung cancer	0.000564	0.00363	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000562	0.00362	CcSEcCtD
Drospirenone—Myocardial infarction—Paclitaxel—lung cancer	0.00056	0.00361	CcSEcCtD
Drospirenone—Angiopathy—Gemcitabine—lung cancer	0.000556	0.00358	CcSEcCtD
Drospirenone—BCHE—lymph node—lung cancer	0.000549	0.011	CbGeAlD
Drospirenone—Gastrointestinal disorder—Topotecan—lung cancer	0.000547	0.00353	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Erlotinib—lung cancer	0.000541	0.00349	CcSEcCtD
Drospirenone—Nervous system disorder—Vinorelbine—lung cancer	0.000532	0.00343	CcSEcCtD
Drospirenone—Skin disorder—Vinorelbine—lung cancer	0.000526	0.00339	CcSEcCtD
Drospirenone—Haemoglobin—Paclitaxel—lung cancer	0.000516	0.00332	CcSEcCtD
Drospirenone—Haemorrhage—Paclitaxel—lung cancer	0.000513	0.00331	CcSEcCtD
Drospirenone—Nausea—Teniposide—lung cancer	0.000508	0.00327	CcSEcCtD
Drospirenone—Erythema multiforme—Etoposide—lung cancer	0.000495	0.00319	CcSEcCtD
Drospirenone—Erythema multiforme—Paclitaxel—lung cancer	0.000485	0.00313	CcSEcCtD
Drospirenone—Acute coronary syndrome—Docetaxel—lung cancer	0.000478	0.00308	CcSEcCtD
Drospirenone—Myocardial infarction—Docetaxel—lung cancer	0.000475	0.00306	CcSEcCtD
Drospirenone—Angiopathy—Etoposide—lung cancer	0.000475	0.00306	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000468	0.00302	CcSEcCtD
Drospirenone—Angiopathy—Paclitaxel—lung cancer	0.000466	0.003	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—lung cancer	0.000462	0.00298	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000451	0.00291	CcSEcCtD
Drospirenone—Mental disorder—Paclitaxel—lung cancer	0.00045	0.0029	CcSEcCtD
Drospirenone—Nervous system disorder—Irinotecan—lung cancer	0.000438	0.00283	CcSEcCtD
Drospirenone—Haemoglobin—Docetaxel—lung cancer	0.000437	0.00282	CcSEcCtD
Drospirenone—Haemorrhage—Docetaxel—lung cancer	0.000435	0.0028	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—lung cancer	0.000429	0.00277	CcSEcCtD
Drospirenone—Nervous system disorder—Gemcitabine—lung cancer	0.000427	0.00275	CcSEcCtD
Drospirenone—PTGS2—lymph node—lung cancer	0.000423	0.00848	CbGeAlD
Drospirenone—Skin disorder—Gemcitabine—lung cancer	0.000423	0.00273	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00042	0.00271	CcSEcCtD
Drospirenone—Erythema multiforme—Docetaxel—lung cancer	0.000411	0.00265	CcSEcCtD
Drospirenone—Breast disorder—Methotrexate—lung cancer	0.000409	0.00264	CcSEcCtD
Drospirenone—Cerebrovascular accident—Doxorubicin—lung cancer	0.0004	0.00258	CcSEcCtD
Drospirenone—Nervous system disorder—Cisplatin—lung cancer	0.000398	0.00257	CcSEcCtD
Drospirenone—Angiopathy—Docetaxel—lung cancer	0.000395	0.00254	CcSEcCtD
Drospirenone—Skin disorder—Cisplatin—lung cancer	0.000394	0.00254	CcSEcCtD
Drospirenone—Nausea—Vinblastine—lung cancer	0.000387	0.0025	CcSEcCtD
Drospirenone—Affect lability—Doxorubicin—lung cancer	0.000386	0.00249	CcSEcCtD
Drospirenone—Migraine—Doxorubicin—lung cancer	0.000386	0.00249	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Irinotecan—lung cancer	0.000386	0.00249	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000385	0.00248	CcSEcCtD
Drospirenone—Mental disorder—Docetaxel—lung cancer	0.000381	0.00246	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000378	0.00243	CcSEcCtD
Drospirenone—Nausea—Topotecan—lung cancer	0.000376	0.00243	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000376	0.00242	CcSEcCtD
Drospirenone—Nausea—Erlotinib—lung cancer	0.000372	0.0024	CcSEcCtD
Drospirenone—Mood swings—Doxorubicin—lung cancer	0.000372	0.0024	CcSEcCtD
Drospirenone—Skin disorder—Etoposide—lung cancer	0.000361	0.00233	CcSEcCtD
Drospirenone—Nervous system disorder—Paclitaxel—lung cancer	0.000358	0.0023	CcSEcCtD
Drospirenone—Breast disorder—Doxorubicin—lung cancer	0.000355	0.00229	CcSEcCtD
Drospirenone—Skin disorder—Paclitaxel—lung cancer	0.000354	0.00228	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Cisplatin—lung cancer	0.00035	0.00226	CcSEcCtD
Drospirenone—Depression—Methotrexate—lung cancer	0.000348	0.00224	CcSEcCtD
Drospirenone—Nausea—Vinorelbine—lung cancer	0.000322	0.00207	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Etoposide—lung cancer	0.000321	0.00207	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00032	0.00206	CcSEcCtD
Drospirenone—Haemoglobin—Methotrexate—lung cancer	0.000315	0.00203	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000315	0.00203	CcSEcCtD
Drospirenone—Haemorrhage—Methotrexate—lung cancer	0.000313	0.00202	CcSEcCtD
Drospirenone—Nervous system disorder—Docetaxel—lung cancer	0.000303	0.00195	CcSEcCtD
Drospirenone—Skin disorder—Docetaxel—lung cancer	0.0003	0.00193	CcSEcCtD
Drospirenone—Erythema multiforme—Methotrexate—lung cancer	0.000296	0.00191	CcSEcCtD
Drospirenone—Megestrol acetate—ABCB1—lung cancer	0.000295	0.0649	CrCbGaD
Drospirenone—Hydrocortisone—ABCG2—lung cancer	0.000293	0.0644	CrCbGaD
Drospirenone—Angiopathy—Methotrexate—lung cancer	0.000284	0.00183	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—lung cancer	0.000275	0.00177	CcSEcCtD
Drospirenone—Haemoglobin—Doxorubicin—lung cancer	0.000273	0.00176	CcSEcCtD
Drospirenone—Haemorrhage—Doxorubicin—lung cancer	0.000271	0.00175	CcSEcCtD
Drospirenone—Progesterone—CYP2A6—lung cancer	0.000267	0.0586	CrCbGaD
Drospirenone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000267	0.00172	CcSEcCtD
Drospirenone—Nausea—Irinotecan—lung cancer	0.000266	0.00171	CcSEcCtD
Drospirenone—Nausea—Gemcitabine—lung cancer	0.000259	0.00167	CcSEcCtD
Drospirenone—Erythema multiforme—Doxorubicin—lung cancer	0.000257	0.00165	CcSEcCtD
Drospirenone—Angiopathy—Doxorubicin—lung cancer	0.000246	0.00159	CcSEcCtD
Drospirenone—Nausea—Cisplatin—lung cancer	0.000241	0.00155	CcSEcCtD
Drospirenone—Mental disorder—Doxorubicin—lung cancer	0.000238	0.00153	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000231	0.00149	CcSEcCtD
Drospirenone—Testosterone—ABCG2—lung cancer	0.000226	0.0496	CrCbGaD
Drospirenone—Nausea—Etoposide—lung cancer	0.000221	0.00142	CcSEcCtD
Drospirenone—Nervous system disorder—Methotrexate—lung cancer	0.000218	0.00141	CcSEcCtD
Drospirenone—Nausea—Paclitaxel—lung cancer	0.000217	0.0014	CcSEcCtD
Drospirenone—Skin disorder—Methotrexate—lung cancer	0.000216	0.00139	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.0002	0.00129	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Methotrexate—lung cancer	0.000192	0.00124	CcSEcCtD
Drospirenone—Nervous system disorder—Doxorubicin—lung cancer	0.000189	0.00122	CcSEcCtD
Drospirenone—Skin disorder—Doxorubicin—lung cancer	0.000187	0.00121	CcSEcCtD
Drospirenone—Progesterone—CYP1A1—lung cancer	0.000187	0.0411	CrCbGaD
Drospirenone—Spironolactone—ABCB1—lung cancer	0.000184	0.0403	CrCbGaD
Drospirenone—Nausea—Docetaxel—lung cancer	0.000184	0.00118	CcSEcCtD
Drospirenone—Norethindrone—ALB—lung cancer	0.000179	0.0392	CrCbGaD
Drospirenone—Testosterone—CYP1A1—lung cancer	0.000177	0.0388	CrCbGaD
Drospirenone—Norethindrone—ABCB1—lung cancer	0.000171	0.0374	CrCbGaD
Drospirenone—Methyltestosterone—ALB—lung cancer	0.00017	0.0373	CrCbGaD
Drospirenone—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000166	0.00107	CcSEcCtD
Drospirenone—Nausea—Methotrexate—lung cancer	0.000132	0.000853	CcSEcCtD
Drospirenone—Hydrocortisone—ABCB1—lung cancer	0.000122	0.0268	CrCbGaD
Drospirenone—Nausea—Doxorubicin—lung cancer	0.000115	0.000738	CcSEcCtD
Drospirenone—Progesterone—ABCB1—lung cancer	9.94e-05	0.0218	CrCbGaD
Drospirenone—Testosterone—ALB—lung cancer	9.85e-05	0.0216	CrCbGaD
Drospirenone—Testosterone—ABCB1—lung cancer	9.4e-05	0.0206	CrCbGaD
Drospirenone—PGR—Signaling Pathways—PTHLH—lung cancer	4.47e-05	0.000423	CbGpPWpGaD
Drospirenone—AR—Gene Expression—JUNB—lung cancer	4.43e-05	0.000418	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTMR3—lung cancer	4.39e-05	0.000415	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKR1C1—lung cancer	4.35e-05	0.000411	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	4.3e-05	0.000406	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PGAM1—lung cancer	4.28e-05	0.000404	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—UGT1A1—lung cancer	4.22e-05	0.000399	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ERCC2—lung cancer	4.22e-05	0.000399	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ANXA1—lung cancer	4.21e-05	0.000398	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SKI—lung cancer	4.21e-05	0.000398	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	4.18e-05	0.000395	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	4.18e-05	0.000395	CbGpPWpGaD
Drospirenone—PTGS2—Disease—B4GALT5—lung cancer	4.08e-05	0.000386	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2A7—lung cancer	4.08e-05	0.000386	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FLT1—lung cancer	4.07e-05	0.000385	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GNG11—lung cancer	4.07e-05	0.000385	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.05e-05	0.000383	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—lung cancer	4.05e-05	0.000383	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.05e-05	0.000383	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.05e-05	0.000383	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.04e-05	0.000382	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SDC4—lung cancer	3.99e-05	0.000377	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH3—lung cancer	3.99e-05	0.000377	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APP—lung cancer	3.99e-05	0.000377	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF9—lung cancer	3.96e-05	0.000374	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALDOA—lung cancer	3.88e-05	0.000367	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	3.85e-05	0.000364	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MYC—lung cancer	3.81e-05	0.00036	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JUNB—lung cancer	3.78e-05	0.000357	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NCOA3—lung cancer	3.77e-05	0.000356	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	3.75e-05	0.000354	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—lung cancer	3.71e-05	0.000351	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.7e-05	0.00035	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	3.69e-05	0.000349	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADCY1—lung cancer	3.66e-05	0.000346	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCG2—lung cancer	3.66e-05	0.000346	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP1—lung cancer	3.66e-05	0.000346	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PXN—lung cancer	3.65e-05	0.000345	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.65e-05	0.000345	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—RRM1—lung cancer	3.64e-05	0.000344	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTA3—lung cancer	3.64e-05	0.000344	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ENO2—lung cancer	3.59e-05	0.00034	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HPGDS—lung cancer	3.59e-05	0.00034	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKR1C1—lung cancer	3.58e-05	0.000338	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPP2R1B—lung cancer	3.57e-05	0.000337	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.52e-05	0.000333	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTT1—lung cancer	3.48e-05	0.000329	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.45e-05	0.000326	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP2A6—lung cancer	3.44e-05	0.000326	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GCLC—lung cancer	3.44e-05	0.000326	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.43e-05	0.000324	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STK11—lung cancer	3.43e-05	0.000324	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—B4GALT5—lung cancer	3.42e-05	0.000323	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.36e-05	0.000317	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTA4—lung cancer	3.33e-05	0.000314	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FOXO3—lung cancer	3.31e-05	0.000313	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NPPA—lung cancer	3.29e-05	0.000311	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.28e-05	0.00031	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ENO1—lung cancer	3.26e-05	0.000309	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.25e-05	0.000307	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.25e-05	0.000307	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTA2—lung cancer	3.24e-05	0.000306	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPIA—lung cancer	3.21e-05	0.000304	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ERCC2—lung cancer	3.21e-05	0.000304	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.21e-05	0.000304	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ALDOA—lung cancer	3.19e-05	0.000301	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTA1—lung cancer	3.13e-05	0.000296	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AVP—lung cancer	3.1e-05	0.000293	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.1e-05	0.000293	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MAPK3—lung cancer	3.09e-05	0.000292	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCC3—lung cancer	3.09e-05	0.000292	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—CREBBP—lung cancer	3.09e-05	0.000292	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—POMC—lung cancer	3.04e-05	0.000288	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ADCY1—lung cancer	3.01e-05	0.000285	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—lung cancer	3.01e-05	0.000284	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKR1C1—lung cancer	3e-05	0.000283	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1R—lung cancer	2.99e-05	0.000282	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO2—lung cancer	2.95e-05	0.000279	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SMARCA4—lung cancer	2.93e-05	0.000277	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPP2R1B—lung cancer	2.93e-05	0.000277	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HES1—lung cancer	2.93e-05	0.000277	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP2E1—lung cancer	2.93e-05	0.000277	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—UGT1A1—lung cancer	2.91e-05	0.000275	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—lung cancer	2.9e-05	0.000274	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NQO1—lung cancer	2.9e-05	0.000274	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.85e-05	0.000269	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.84e-05	0.000268	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—lung cancer	2.83e-05	0.000268	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—lung cancer	2.83e-05	0.000267	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.81e-05	0.000266	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GNG11—lung cancer	2.8e-05	0.000265	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.79e-05	0.000264	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.76e-05	0.000261	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO1—lung cancer	2.68e-05	0.000254	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB3—lung cancer	2.68e-05	0.000253	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDOA—lung cancer	2.67e-05	0.000252	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—STK11—lung cancer	2.61e-05	0.000247	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOA3—lung cancer	2.59e-05	0.000245	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TERT—lung cancer	2.57e-05	0.000243	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.55e-05	0.000241	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADCY1—lung cancer	2.52e-05	0.000238	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCG2—lung cancer	2.52e-05	0.000238	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGFR1—lung cancer	2.5e-05	0.000236	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APP—lung cancer	2.49e-05	0.000236	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF9—lung cancer	2.47e-05	0.000234	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HPGDS—lung cancer	2.47e-05	0.000234	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO2—lung cancer	2.47e-05	0.000234	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIF1A—lung cancer	2.46e-05	0.000232	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPP2R1B—lung cancer	2.46e-05	0.000232	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.45e-05	0.000232	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.42e-05	0.000229	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTP1—lung cancer	2.42e-05	0.000228	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTT1—lung cancer	2.4e-05	0.000227	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOA1—lung cancer	2.37e-05	0.000224	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2A6—lung cancer	2.37e-05	0.000224	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GCLC—lung cancer	2.37e-05	0.000224	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JUNB—lung cancer	2.36e-05	0.000223	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.36e-05	0.000223	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—lung cancer	2.35e-05	0.000223	CbGpPWpGaD
Drospirenone—AR—Gene Expression—CREBBP—lung cancer	2.35e-05	0.000222	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KDR—lung cancer	2.35e-05	0.000222	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CAT—lung cancer	2.35e-05	0.000222	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.34e-05	0.000221	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.33e-05	0.00022	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCB1—lung cancer	2.29e-05	0.000216	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO1—lung cancer	2.25e-05	0.000212	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TYMS—lung cancer	2.25e-05	0.000212	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.24e-05	0.000212	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTM1—lung cancer	2.22e-05	0.00021	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.21e-05	0.000209	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APC—lung cancer	2.17e-05	0.000205	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KIT—lung cancer	2.17e-05	0.000205	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CG—lung cancer	2.17e-05	0.000205	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGF—lung cancer	2.14e-05	0.000202	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1A1—lung cancer	2.1e-05	0.000199	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ERCC2—lung cancer	2.09e-05	0.000197	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—lung cancer	2.09e-05	0.000197	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FOXO3—lung cancer	2.07e-05	0.000196	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—POMC—lung cancer	2.06e-05	0.000195	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BRAF—lung cancer	2.04e-05	0.000192	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2E1—lung cancer	2.02e-05	0.000191	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6R—lung cancer	2.01e-05	0.00019	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CREBBP—lung cancer	2.01e-05	0.00019	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NQO1—lung cancer	1.99e-05	0.000188	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.95e-05	0.000184	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAP2K1—lung cancer	1.92e-05	0.000181	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CD—lung cancer	1.9e-05	0.00018	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MAPK3—lung cancer	1.88e-05	0.000178	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HES1—lung cancer	1.83e-05	0.000173	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—lung cancer	1.83e-05	0.000173	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOA1—lung cancer	1.81e-05	0.000171	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—STK11—lung cancer	1.8e-05	0.00017	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.73e-05	0.000163	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERCC2—lung cancer	1.71e-05	0.000162	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MDM2—lung cancer	1.71e-05	0.000161	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RAF1—lung cancer	1.7e-05	0.000161	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.69e-05	0.000159	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB2—lung cancer	1.68e-05	0.000159	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB3—lung cancer	1.68e-05	0.000159	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTP1—lung cancer	1.66e-05	0.000157	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CB—lung cancer	1.66e-05	0.000157	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MTOR—lung cancer	1.66e-05	0.000157	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CG—lung cancer	1.65e-05	0.000156	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CAT—lung cancer	1.62e-05	0.000153	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.61e-05	0.000152	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TERT—lung cancer	1.61e-05	0.000152	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—lung cancer	1.59e-05	0.000151	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCB1—lung cancer	1.57e-05	0.000149	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—POMC—lung cancer	1.57e-05	0.000148	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGFR1—lung cancer	1.56e-05	0.000148	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TYMS—lung cancer	1.55e-05	0.000146	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIF1A—lung cancer	1.54e-05	0.000145	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CREBBP—lung cancer	1.53e-05	0.000144	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTM1—lung cancer	1.53e-05	0.000144	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—lung cancer	1.53e-05	0.000144	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—lung cancer	1.52e-05	0.000144	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—lung cancer	1.49e-05	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOA1—lung cancer	1.48e-05	0.00014	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JUN—lung cancer	1.48e-05	0.00014	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CD—lung cancer	1.45e-05	0.000137	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1A1—lung cancer	1.45e-05	0.000137	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—lung cancer	1.44e-05	0.000136	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—lung cancer	1.44e-05	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ERCC2—lung cancer	1.44e-05	0.000136	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MAPK3—lung cancer	1.44e-05	0.000136	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTEN—lung cancer	1.43e-05	0.000135	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—lung cancer	1.43e-05	0.000135	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—lung cancer	1.4e-05	0.000132	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EP300—lung cancer	1.37e-05	0.000129	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APC—lung cancer	1.35e-05	0.000128	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KIT—lung cancer	1.35e-05	0.000128	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGF—lung cancer	1.34e-05	0.000127	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SRC—lung cancer	1.33e-05	0.000126	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—lung cancer	1.29e-05	0.000122	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—lung cancer	1.28e-05	0.000121	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRAS—lung cancer	1.28e-05	0.000121	CbGpPWpGaD
Drospirenone—PTGS2—Disease—BRAF—lung cancer	1.27e-05	0.00012	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—lung cancer	1.27e-05	0.00012	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CB—lung cancer	1.26e-05	0.000119	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6R—lung cancer	1.26e-05	0.000119	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CREBBP—lung cancer	1.26e-05	0.000119	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—lung cancer	1.25e-05	0.000118	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOA1—lung cancer	1.24e-05	0.000117	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK3—lung cancer	1.22e-05	0.000116	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAP2K1—lung cancer	1.2e-05	0.000113	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—lung cancer	1.19e-05	0.000113	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CD—lung cancer	1.19e-05	0.000113	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.19e-05	0.000112	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—lung cancer	1.17e-05	0.00011	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CG—lung cancer	1.13e-05	0.000107	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—lung cancer	1.1e-05	0.000104	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTEN—lung cancer	1.09e-05	0.000103	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—POMC—lung cancer	1.08e-05	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MDM2—lung cancer	1.07e-05	0.000101	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RAF1—lung cancer	1.06e-05	0.0001	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CREBBP—lung cancer	1.05e-05	9.94e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB2—lung cancer	1.05e-05	9.94e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—EP300—lung cancer	1.04e-05	9.84e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTOR—lung cancer	1.04e-05	9.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CB—lung cancer	1.04e-05	9.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD4—lung cancer	1.04e-05	9.79e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—lung cancer	1.01e-05	9.56e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CD—lung cancer	9.97e-06	9.42e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—lung cancer	9.84e-06	9.3e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—lung cancer	9.78e-06	9.25e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—lung cancer	9.68e-06	9.15e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—lung cancer	9.36e-06	8.84e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—lung cancer	8.99e-06	8.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTEN—lung cancer	8.97e-06	8.48e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—lung cancer	8.96e-06	8.46e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CB—lung cancer	8.69e-06	8.21e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EP300—lung cancer	8.55e-06	8.08e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SRC—lung cancer	8.32e-06	7.86e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—lung cancer	8.26e-06	7.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—lung cancer	8.02e-06	7.58e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRAS—lung cancer	8e-06	7.56e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—lung cancer	7.7e-06	7.28e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK3—lung cancer	7.66e-06	7.24e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTEN—lung cancer	7.51e-06	7.1e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—lung cancer	7.45e-06	7.04e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—lung cancer	7.29e-06	6.89e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—EP300—lung cancer	7.16e-06	6.77e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—lung cancer	6.89e-06	6.51e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—lung cancer	6.33e-06	5.98e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—lung cancer	6.29e-06	5.94e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—lung cancer	5.85e-06	5.53e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—lung cancer	5.6e-06	5.3e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—lung cancer	5.3e-06	5.01e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—lung cancer	5.17e-06	4.88e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—lung cancer	4.33e-06	4.09e-05	CbGpPWpGaD
